BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37951629)

  • 21. Potential Molecular Targets for Treating Neuropathic Orofacial Pain Based on Current Findings in Animal Models.
    Nagakura Y; Nagaoka S; Kurose T
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropathic pain after dental treatment.
    Tınastepe N; Oral K
    Agri; 2013; 25(1):1-6. PubMed ID: 23588863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is Botulinum Toxin Effective in Treating Orofacial Neuropathic Pain Disorders? A Systematic Review.
    Val M; Delcanho R; Ferrari M; Guarda Nardini L; Manfredini D
    Toxins (Basel); 2023 Sep; 15(9):. PubMed ID: 37755967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paroxysmal neuralgia in pediatric population--a diagnostic dilemma for physicians and dental practioners.
    Dubey A; Mujoo S; Sakarde SB; Dubey AK
    Kathmandu Univ Med J (KUMJ); 2012; 10(40):74-7. PubMed ID: 23575058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical application of capsaicin for treatment of oral neuropathic pain and trigeminal neuralgia.
    Epstein JB; Marcoe JH
    Oral Surg Oral Med Oral Pathol; 1994 Feb; 77(2):135-40. PubMed ID: 8139830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trigeminal neuralgia and trigeminal neuropathic pain.
    Ryan K; Crighton A
    Br Dent J; 2024 Feb; 236(4):323-328. PubMed ID: 38388612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GLOSSOPHARYNGEAL NERVE AS A SOURCE OF OROFACIAL PAIN - DIAGNOSTIC AND THERAPEUTIC CHALLENGES.
    Šklebar D; Vučemilo L; Šklebar T
    Acta Clin Croat; 2022 Sep; 61(Suppl 2):90-95. PubMed ID: 36824642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of neuropathic pain conditions affecting teeth.
    Koratkar H; Parashar V; Koratkar S
    Gen Dent; 2010; 58(5):436-41; quiz 442-3. PubMed ID: 20829169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical odontalgia and trigeminal neuralgia: psychological, behavioral and psychopharmacological approach in a dental clinic - an overview of pathologies related to the challenging differential diagnosis in orofacial pain.
    Tizzoni R; Tizzoni M; Clerici CA
    F1000Res; 2021; 10():317. PubMed ID: 35966965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trigeminal nerve anatomy in neuropathic and non-neuropathic orofacial pain patients.
    Wilcox SL; Gustin SM; Eykman EN; Fowler G; Peck CC; Murray GM; Henderson LA
    J Pain; 2013 Aug; 14(8):865-72. PubMed ID: 23685183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AAPT Diagnostic Criteria for Peripheral Neuropathic Pain: Focal and Segmental Disorders.
    Freeman R; Edwards R; Baron R; Bruehl S; Cruccu G; Dworkin RH; Haroutounian S
    J Pain; 2019 Apr; 20(4):369-393. PubMed ID: 30527971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gasserian ganglion injected with Adriamycin successfully relieves intractable trigeminal nerve postherpetic neuralgia for an elderly patient: A case report.
    Zheng B; Song L; Liu H
    Medicine (Baltimore); 2018 Sep; 97(38):e12388. PubMed ID: 30235706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infusion Therapy in the Treatment of Neuropathic Pain.
    McMullin PR; Hynes AT; Arefin MA; Saeed M; Gandhavadi S; Arefin N; Eckmann MS
    Curr Pain Headache Rep; 2022 Sep; 26(9):693-699. PubMed ID: 35794449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An extract of phase II and III trials on recent developments in managing neuropathic pain syndromes: diabetic peripheral neuropathy, trigeminal neuralgia, and postherpetic neuralgia.
    Upshaw WC; Soileau LG; Storey NR; Perkinson KA; Luther PM; Spillers NJ; Robinson CL; Miller BC; Ahmadzadeh S; Viswanath O; Shekoohi S; Kaye AD
    Expert Opin Emerg Drugs; 2024 Jun; 29(2):103-112. PubMed ID: 38410863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The capsaicin 8% patch for neuropathic pain in clinical practice: a retrospective analysis.
    Wagner T; Poole C; Roth-Daniek A
    Pain Med; 2013 Aug; 14(8):1202-11. PubMed ID: 23710678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuromodulators for Atypical Facial Pain and Neuralgias: A Systematic Review and Meta-Analysis.
    Do TM; Unis GD; Kattar N; Ananth A; McCoul ED
    Laryngoscope; 2021 Jun; 131(6):1235-1253. PubMed ID: 33037835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EFNS guidelines on pharmacological treatment of neuropathic pain.
    Attal N; Cruccu G; Haanpää M; Hansson P; Jensen TS; Nurmikko T; Sampaio C; Sindrup S; Wiffen P;
    Eur J Neurol; 2006 Nov; 13(11):1153-69. PubMed ID: 17038030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002-2005.
    Hall GC; Carroll D; McQuay HJ
    BMC Fam Pract; 2008 May; 9():26. PubMed ID: 18460194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Narrative Review of Therapeutic Peripheral Nerve Blocks for Chronic Orofacial Pain Conditions.
    Renton T; Beke A
    J Oral Facial Pain Headache; 2022 Winter; 36(1):49-58. PubMed ID: 35298575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurovascular compression of the trigeminal and glossopharyngeal nerve: three case reports.
    Childs AM; Meaney JF; Ferrie CD; Holland PC
    Arch Dis Child; 2000 Apr; 82(4):311-5. PubMed ID: 10735840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.